SCHEMBL6168601

SCHEMBL6168601

CCOC(=O)C(OC(C)=O)(C(=O)OCC)c1c(C(=O)c2cccc(C)c2)[nH]c2ccc(OC)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.48
MAPT P10636 4/20 0.48
MEN1 O00255 4/20 0.48
GAA P10253 4/20 0.48
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 5/20 0.47
HPGD P15428 4/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HSD17B10 Q99714 5/20 0.46
TUBB4A P04350 4/20 0.45
TUBB P07437 4/20 0.45
TUBA3C P0DPH7 4/20 0.45
TUBA1B P68363 4/20 0.45
TUBA4A P68366 4/20 0.45
TUBB4B P68371 4/20 0.45
TUBB3 Q13509 4/20 0.45
TUBB2A Q13885 4/20 0.45
TUBB8 Q3ZCM7 4/20 0.45
TUBA3E Q6PEY2 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170441 0.88 ALDH1A1 (0.45) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL6169624 0.82 ALOX15 (0.47) ALDH1A1HPGDELANECYP1A2CYP2C19
SCHEMBL6168370 0.82 ALDH1A1 (0.46) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL6169500 0.79 MAPT (0.44) KMT2AMAPTGAAALDH1A1KDM4E
SCHEMBL6171922 0.79 L3MBTL1 (0.41) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL27569322 0.78 KMT2A (0.46) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7203928 0.78 ALDH1A1 (0.52) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL6171751 0.77 ALDH1A1 (0.46) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL6172066 0.76 ALOX15 (0.48) ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL6169448 0.76 ALDH1A1 (0.39) KMT2AMAPTMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed